Company Filing History:
1 out of 33 
1 out of 1 
1 out of 1 Years Active: 2017
Title: Bruno Saint-Jean: Innovator in Glycosylation Technology
Introduction
Bruno Saint-Jean is a notable inventor based in Nantes, France. He has made significant contributions to the field of biotechnology, particularly in the area of glycosylation processes. His work has implications for the production of glycosylated polypeptides, which are essential in various biopharmaceutical applications.
Latest Patents
Bruno Saint-Jean holds a patent that focuses on a transformed organism containing a nucleic acid sequence operatively linked to a promoter. This sequence encodes an N-acetylglucosaminyltransferase I and/or an α-Mannosidase II. Importantly, at least one β-N-acetylglucosaminidase of the transformed organism has been inactivated. The patent describes a method for producing a glycosylated polypeptide, which includes culturing the transformed organism and purifying the expressed and glycosylated polypeptide.
Career Highlights
Throughout his career, Bruno has worked with esteemed institutions such as Université de Rouen and L'Institut Français de Recherche pour l'Exploitation de la Mer (Ifremer). His experience in these organizations has allowed him to develop and refine his innovative approaches to biotechnology.
Collaborations
Bruno has collaborated with notable colleagues, including Muriel Bardor and Romain Louvet. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Bruno Saint-Jean is a distinguished inventor whose work in glycosylation technology has the potential to impact the biopharmaceutical industry significantly. His innovative approaches and collaborations continue to drive advancements in biotechnology.